Proven DNBSEQ™ sequencing technology combines the power of DNA Nanoballs (DNB™), PCR-free Rolling Circle Replication, Patterned Nano Arrays and cPAS to deliver a new level of data clarity and affordability.

Learn About DNBSEQ™ Technology

BGI is the world’s leading healthcare integrated solutions provider. We provide fully integrated genomic sequencing, proteomic services, and more.

Human Whole Genome Sequencing

Exome Sequencing

Epigenetics Sequencing

Plant/Animal Whole Genome Sequencing

RNA Sequencing

Small RNA Sequencing

16s/18s/ITS Sequencing

Metagenomic Sequencing

Single Cell Sequencing

We provide researchers and healthcare professionals with the highest quality multi-omics data, at rapid turnaround times, with the best possible scientific support, all at industry leading pricing. Find our sequencing services and genomics solutions below.

BGI - high quality, affordable sequencing services and NGS solutions.

<img src="https://www.bgi.com/api/assets/f100d04b-513a-46cf-81e1-dfbb405f5b2b" width="100%"/>Photo taken on May 4, 2022 shows samples for COVID-19 tests in the inflatable COVID-19 testing lab Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde) BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic.The BGI Health Ethiopia administers Huo-Yan Air Lab inside the premises of Addis Ababa Bole International Airport, Ethiopia's main international hub and Africa's busiest and leading gateway.<img src="https://www.bgi.com/api/assets/6e8797de-9983-4ca7-8a15-adbb8038d25d" width="100%"/>Photo taken on May 4, 2022 shows a biological laboratory engineer working in the inflatable COVID-19 testing lab Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde)Eyuel Fikru, one of the Ethiopian health experts working as local team coordinator at the Huo-Yan Air Lab, said the company has introduced the latest technologies and equipment to conduct COVID-19 testing and has shared good knowledge on modern COVID-19 testing technology with local health professionals.<img src="https://www.bgi.com/api/assets/e5a6a56d-af19-4525-b937-46500d898508" width="100%"/>Photo taken on May 4, 2022 shows Eyuel Fikru, a local team coordinator at the inflatable COVID-19 testing lab Huo-Yan Air Lab, speaking during an interview at Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde)<span style="letter-spacing: 0px; font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, &quot;Helvetica Neue&quot;, Arial, &quot;Noto Sans&quot;, sans-serif, &quot;Apple Color Emoji&quot;, &quot;Segoe UI Emoji&quot;, &quot;Segoe UI Symbol&quot;, &quot;Noto Color Emoji&quot;;">"The equipment and the steps that we are following are really new and special. It is somehow a good way of capacity building and transfer of knowledge to the local health experts," said Fikru in a recent interview with Xinhua. The laboratory conducts up to 1,000 COVID-19 tests per day using a rapid detection and diagnosis technology and notifies results three hours before passengers get on board to travel to China and other parts of the world."The test is reliable, specific and sensitive," said Fikru, emphasizing that the laboratory plays a significant role for Ethiopian airlines to conduct infection-free flights and help the East African nation fight the COVID-19 pandemic."Working with Chinese colleagues and the BGI as a whole is a good opportunity for Ethiopian medical practitioners since we are grabbing a lot of knowledge, especially on the machines and instruments in addition to developing good work ethics," he said.Appreciating the sampling techniques, timing and high-quality working instruments at Huo-Yan Air Lab, Fikru said that the technology transfer is paying off to expand similar services across the country."After joining the BGI, I have come across sophisticated, newly emerging sample collections and get familiar with advanced technology including QPCR machines that can test 96 samples at one cycle," he added.On top of producing reliable COVID-19 test results, the laboratory helps the airlines carry on flights without any worries of infections on board and interruptions of flights, he said.<img src="https://www.bgi.com/api/assets/3321ebbd-fee0-4c66-a6e8-58368d1172dc" width="100%"/>Photo taken on May 4, 2022 shows Kominist Asmamaw, a biological laboratory engineer at BGI Health Ethiopia, working in the inflatable COVID-19 testing lab Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde)<img src="https://www.bgi.com/api/assets/d2011b37-b174-4824-ba7d-3fc1290e8d5b" width="100%"/>Photo taken on May 4, 2022 shows Kominist Asmamaw, a biological laboratory engineer at BGI Health Ethiopia, working in the inflatable COVID-19 testing lab Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde)Kominist Asmamaw is another health expert, who works as a biological laboratory engineer at the state-of-the-art lab."Working with Chinese colleagues has helped me gain good experience, set up programs for all the COVID-19 testing machines and operate them independently," said Asmamaw, appreciating the state of the art testing instruments, equipment and machines at Huo-Yan laboratory."This lab is one of the well-equipped Laboratories in Ethiopia. I have never seen this kind of laboratory which is equipped with state-of-the-art automatic machines," Asmamaw said.<img src="https://www.bgi.com/api/assets/dca977bd-3a43-4ace-a2c5-d31aa01ac5a1" width="100%"/>Photo taken on May 4, 2022 shows BGI Health Ethiopia PLC Administration Director Saron Tamirat speaking during an interview at the inflatable COVID-19 testing lab Huo-Yan Air Lab at the Addis Ababa Bole International Airport, Ethiopia. BGI Health Ethiopia, a subsidiary of China's biotech giant, the BGI Genomics Co., Ltd., has won acclaim for its technology and knowledge transfer endeavors to propel Ethiopia's fight against the COVID-19 pandemic. (Xinhua/Michael Tewelde)BGI Health Ethiopia PLC Administration Director Saron Tamirat said the Huo-Yan Air Lab has been producing accurate and precise COVID-19 test results for passengers traveling to China."This laboratory has played a big role in COVID-19 management in Ethiopia. We produce test kits and bring them here to provide testing services which happen to be very accurate and very precise," Tamirat told Xinhua.Emphasizing that detection capacity is a milestone for a country to prevent and control COVID-19 infections, Tamirat said "the laboratory helped the Ethiopian airlines to have uninterrupted flights to China and other parts of the world."BGI Health Ethiopia also opened the first Chinese reagent factory in Ethiopia in September 2020, which has a production capacity of 6 million SARS-COV-2 RT PCR detection kits per year. The testing kits are widely used in Ethiopia and in other African countries for antigen rapid tests, particularly at airports and land entry checkpoints."The company is presently providing its COVID-19 test kits to the public and private diagnostic centers, eventually contributing to the East African country's fight against the COVID-19 pandemic," Tamirat added.&nbsp; Source:&nbsp;<a target="_blank" href="https://english.news.cn/20220518/366add7b562c4c57995c3b280d61f193/c.html">Xinhua News</a>

5.jpeg

Xinhua News | Feature: Chinese company wins acclaim for technology transfer endeavors to drive Ethiopia's fight against COVID-19

<img src="https://www.bgi.com/api/assets/e65cf0de-8a77-4fa8-8a15-39488c47574e" style="max-width:100%;" contenteditable="false"/>BGI has provided commercial RNA sequencing (RNA-Seq) services for&nbsp;over 20 years and supported researchers worldwide to publish paradigm changing RNA papers in top-tier journals. With services offered on our&nbsp;DNBSEQ sequencing, we deliver&nbsp;quality RNA data that enables cutting-edge transcriptomics&nbsp;research at affordable pricing.&nbsp;Whatever your project, species, or sample type, we are confident our RNA-Seq service will meet both your data quality expectations and your budget. Contact us today for a free quote!<h3></h3><h3 id="w76yo"> </h3><h3 id="w76yo">DNBSEQ Eukaryotic&nbsp;Stranded&nbsp;Transcriptome&nbsp;Sequencing</h3>·&nbsp;Library + Sequencing&nbsp;from&nbsp;$129 ·&nbsp;Library + Sequencing + Standard Analysis from $169<h3 id="1wjw4"></h3><h3 id="2s15a">DNBSEQ Whole Transcriptome&nbsp;Sequencing(LncRNA-Seq + UMI small RNA-Seq)</h3>·&nbsp;Library + Sequencing&nbsp;from&nbsp;$399 ·&nbsp;Library + Sequencing + Standard Analysis from $499 <div>Key Terms and Conditions:-&nbsp;For&nbsp;sequencing&nbsp;services,&nbsp;sign contract before June 30th, 2022 and&nbsp;submit&nbsp;samples before&nbsp;Dec.&nbsp;31th, 2022.-&nbsp;This is a limited and conditional offer subject to the actual execution of contract, and BGI reserves the right to void the promotion and revert to its standard list prices if the Partner does not comply with the conditions listed above.-&nbsp;Services are for research use only. <h4 id="1yw9l"><a target="_blank" href="https://www.flipsnack.com/BDEEDDFF8D6/special-promotion-for-dnbseq-rna-sequencing-zu8o9kco7k/full-view.html">Download the flyer</a>&nbsp;or&nbsp;<a target="_blank" href="mailto:info@bgi.com">Contact us</a>&nbsp;for more details!</h4></div>

微信图片_20220516150200.jpg

Special Promotion for DNBSEQ RNA Sequencing

<img src="https://www.bgi.com/api/assets/4191ef38-5eb5-46a6-b614-dd599e2b0bf1" style="max-width:100%;" contenteditable="false"/>A new ISO technical specification will improve testing procedures and contribute to a safer world. The COVID pandemic first reared its head in 2019 and despite concerted efforts from authorities and the public, it's still with us.&nbsp;Recently published,&nbsp;<a href="https://www.iso.org/standard/81712.html">ISO/TS&nbsp;5798</a>&nbsp;provides recommendations for the design, development, verification, validation and implementation of analytical tests for detecting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) using nucleic acid amplification. It addresses pre-examination, examination and post-examination process steps for human specimens.We find out more about the technical specification with dedicated standardizer and biology expert&nbsp;Dr Ye Yin. Most of us know that there are various types of COVID test available, but the new technical specification uses nucleic acid testing. Can you tell us how that works? Ye:&nbsp;The discovery of DNA in 1953&nbsp;enabled a new&nbsp;era in molecular biology, moving pathogen research&nbsp;forward from the morphological level to the molecular level. Nucleic acid testing, which operates on this molecular level, has gradually become the mainstream of pathogen detection. That's partly because it can provide direct detection without prior isolation and culture of pathogens, making it&nbsp;convenient, fast and highly sensitive.Such tests use a&nbsp;nucleic acid hybridization technique that is based on double-stranded complementary pairing of nucleic acids. Basically,&nbsp; technicians synthesize a single-stranded nucleic acid sequence complementary to the DNA or RNA of a specific pathogen as a probe.&nbsp;They would then label it using, for example, radioisotopes or enzymes, and subject it to hybridization with the nucleic acids of the pathogen to be tested. If a probe can be complementarily paired with the nucleic acid of the pathogen to be tested, it is possible to observe the signals of the markers, so that the species of the pathogen to be tested can be confirmed. The specificity and sensitivity of such tests are relatively high and are of crucial significance for the early diagnosis of infectious diseases. How can a new technical specification for SARS-CoV2 testing help us to finally end the COVID pandemic? Ye:&nbsp;COVID-19 has become the most widespread global pandemic in the past 100 years, and it is also the first time that molecular biology genomics has been applied on a super-large scale in response to an emerging outbreak.There are currently three methods for detecting SARS-CoV-2: nucleic acid tests, antigen tests and antibody tests. The nucleic acid test is&nbsp;the ‘gold standard’&nbsp;for pathogenic diagnosis, faster and more accurate than the other methods. But variations in&nbsp;procedures and materials&nbsp;used by laboratory personnel can contribute to variable quality test results.The rapid global spread of COVID-19 meant that&nbsp;a number of testing reagents of varying quality emerged around the world. Establishing clear quality assessment requirements for testing reagents was needed, together with guidance to enable accurate, early diagnosis and screening are essential&nbsp;to control the spread of the pandemic and treat patients in time.&nbsp;&nbsp;Clear guidance was needed urgently needed from ISO, and that's what led to the development of ISO/TS 5798. So what are the main points covered by the new Technical Specification, and who is it aimed at? Ye:&nbsp;ISO/TS 5798 mainly focuses on the use of nucleic acid amplification methods for diagnosis and screening of SARS-CoV-2 and proposes requirements and recommendations for the design, development, validation, verification and implementation of testing methods.But it also&nbsp;covers the steps of the overall process of pre-examination, examination and post-examination for the analysis of nucleic acid amplification method for the detection of SARS-CoV-2, and specifies the methods and comprehensive assessment indicators&nbsp;including accuracy, limit of detection, inclusivity, and specificity, etc.The new standardized guidelines fill a gap in the&nbsp;quality control of&nbsp; testing, and&nbsp; applies to medical laboratories, in vitro diagnostic developers and manufacturers, as well as institutions and organizations in support of research and diagnosis of SARS-CoV-2. Why was a new testing standard needed? What's signficant about ISO/TS 5798? Ye:&nbsp;The new technical specification from&nbsp;ISO&nbsp;is the world's first guidelines for nucleic acid testing of SARS-CoV-2.It not only provides important technical basis and support to global medical laboratories, in vitro diagnostic test reagent developers and manufacturers, as well as institutions and organizations for new coronavirus research, it supports the global response against the pandemic with science and technology. It shares advanced technical achievements and successful experience of SARS-CoV-2 nucleic acid testing around the world, which is also helps to establish&nbsp;&nbsp;reference values for the testing of other viruses and potential epidemics. Are further COVID-related standards needed in order for us to end the pandemic? Ye:&nbsp;The fight against COVID-19 involves not only nucleic acid testing, but also other activities such as&nbsp;infectious disease prevention and control, microbiological testing and public health emergencies response. Since the outbreak of COVID-19, I have been closely following the development of ISO&nbsp; standards related to COVID-19. For example,&nbsp;&nbsp;ISO/TC 147&nbsp;on water quality are currently developing a standard for the testing of SARS-CoV-2 in wastewater, while the&nbsp;ISO Technical Committee on tourism and related services&nbsp;published&nbsp;a publicly available specification that&nbsp;provides safer tourism services and products for tourists and residents.Further standards related to COVID-19 are expected to be released in the future. These standards will jointly build a standard system for addressing COVID-19, guaranteeing the scientific approach, improving the quality of products and facilites&nbsp;for epidemic prevention and control, and contributing to the promotion and replication of excellent epidemic prevention experience. In combination, these ISO standards will help us to&nbsp;take concerted action and win the global battle against COVID-19.Source:&nbsp;<a href="https://www.iso.org/news/ref2798.html" target="_blank">https://www.iso.org/news/ref2798.html</a>

2.png

New guidelines for COVID testing

<img src="https://www.bgi.com/api/assets/77193dcc-4dee-4e4d-ba8b-d14cefe9f98b" style="max-width:100%;" contenteditable="false"/><span style="font-family: -apple-system, BlinkMacSystemFont, &quot;Segoe UI&quot;, Roboto, &quot;Helvetica Neue&quot;, Arial, &quot;Noto Sans&quot;, sans-serif, &quot;Apple Color Emoji&quot;, &quot;Segoe UI Emoji&quot;, &quot;Segoe UI Symbol&quot;, &quot;Noto Color Emoji&quot;; letter-spacing: 0px;">BGI announces that its 2019-nCoV Ag Test (Latex Chromatography Assay) has recently been included in the Australian Register of Therapeutic Goods (ARTG). Therapeutic goods entered in the ARTG can be lawfully supplied in Australia.The test kit is designed for detecting SARS CoV-2 nucleocapsid protein antigen for individuals suspected to have contracted COVID-19. The test is available at the point of care for trained health professionals (nasopharyngeal swabs), and for self-testing by laypersons (nasal swabs).The test solution can assist in diagnosing symptomatic individuals within the first seven days of symptom onset. Self-testing can be easily conducted at home, at schools, at work, etc. It will provide reliable and quick results in 15-30 minutes.

COVID-19 Local Laboratory Solution

COVID-19 Test Kit

Webinars On Demand

News and Events